ArticleMolecular cancer therapeutics2026
Editor's Note: Akt/mTOR Counteract the Antitumor Activities of Cixutumumab, an Anti-Insulin-like Growth Factor I Receptor Monoclonal Antibody.
Dong Hoon Shin et al.PubMed ↗Publisher ↗
No numbers read from the abstract.